https://www.selleckchem.com/pr....oducts/afuresertib-g
FO ILE was used as the sole source of lipids and led to improvement in liver function tests. No evidence of essential fatty acid deficiency was found in either case. Current case presentations and review of literature support the use of FO ILE to increase ω-3 PUFAs in patients with IFALD refractory to MO ILE. Additional research is necessary to delineate the dose of FO ILE necessary to achieve benefit. Current case presentations and review of literature support the use of FO ILE to increase ω-3 PUFAs in patients with IFAL
Like
Comment
Share
